Article
Potent antiviral effect of reverset in HIV-1-infected adults following a single oral dose.
Antiviral therapy - 1 Aug 2004
Stuyver Lieven J, McBrayer Tamara R, Schürmann Dirk, Kravec Irena, Beard Amanda, Cartee Leanne, Schinazi Raymond F, De La Rosa Abel, Murphy Robert L, Otto Michael J
Abstract excerpt
Reverset (2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine, RVT) is a potent inhibitor of HIV-1 replication in cell culture, with a 90% effective concentration at or below 1 microM. In vitro, RVT retains its activity against isolates harbouring mutations in the reverse transcriptase (RT) gene that otherwise confer resistance to lamivudine and/or zidovudine. The pharmacokinetics and safety of single oral doses of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
